Evidence from studies of brand-name GLP-1 medications suggests that weight regain is common after discontinuation, particularly without sustained lifestyle modifications
Injectable drugs like Wegovy and Mounjaro are effective but less convenient than oral formulations and pharmaceutical companies are also pursuing the development of oral weight loss drugs
It has examined current adoption data showing that while ePA is not yet universal, its use is expanding rapidly under industry and regulatory pressure
Our methods used for atrial contraction studies in human samples have been previously published and were not altered in this study (e.g., Gergs et al
Moreover, glutamine-dependent PDAC is sensitive to the SLC7A11 inhibitor erastin, which induces ferroptosis 62,63
Originally approved for treating type 2 diabetes in 2017 under the brand names Ozempic and Rybelsus (oral version), GLP-1 has gained attention for its weight loss effects